Wednesday, 28 November 2018

HARTALEGA latest financial report


Today I would like review the latest financial report of HARTA.

 Frankly speaking,
once I opened the report and saw the increasing revenue,
I was happy:

But my mood totally destroyed after looking at the net profit.....
Aiks.......

 The comparison of same quarter last year:
The revenue increased by 22.2%,
and since the sales volume grew by only 10.6%,
which meant the selling price was much higher.

 Comparing with previous quarter,
the profit dropped by 2.4%:

Mainly because of foreign exchange loss.

 The prospects of the company:
Plant 5 started to commission at August 2018,
while construction of Plant 6 and 7 will be following soon.

 First shipment of AMG have been delivered and the company already received orders from over 10 countries.
Approval from FDA is still in the working.

 As conclusion,
the growth of the company will be relying on the expansion of NGC and the growth of AMG.

 Lastly,
the dividend that everyone loved:
2.2sen per share.

 That's all for the laest financial report of HARTALEGA,
if you want to know more details,
is better to download the report and read by yourselves.

 Investment is about doing own thinking, making own decision.

 Thanks for reading.

I don't provide any buying/selling suggestion above,
please make your own investment decision and be responsible with it.






Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)